Salarius Pharmaceuticals ... (SLRX)
NASDAQ: SLRX
· Real-Time Price · USD
5.76
0.14 (2.49%)
At close: Aug 26, 2025, 3:58 PM
6.25
8.51%
Pre-market: Aug 27, 2025, 07:04 AM EDT
Salarius Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 4.43K | n/a | n/a | n/a | 17.89K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 571.39K | 1.27M |
Cost of Revenue | 1.11K | 1.11K | 2.21K | 1.1K | 1.11K | 1.11K | 1.1K | 5.61K | 1.67K | 1.67K | 1.67K | 1.67K | 2.92M | 4.44M | 1.85M | 4.8K | 2.1M | 1.74M |
Gross Profit | -1.11K | -1.11K | 2.21K | -1.1K | -1.11K | -1.11K | 16.79K | -5.61K | -1.67K | -1.67K | -1.67K | -1.67K | -2.92M | -4.44M | -1.85M | -4.8K | -1.52M | -471.83K |
Operating Income | -957.83K | -1.72M | -1.49M | -1.01M | -1.47M | -1.77M | -970.7K | -2.53M | -3.97M | -5.42M | -6.48M | -5.62M | -4.76M | -6.12M | -4.14M | -3.75M | -3.12M | -1.8M |
Interest Income | 7.74K | 9.16K | 24.78K | 34.35K | 43.08K | 56.33K | 88.91K | 89.37K | n/a | 79.89K | n/a | 78.61K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -957.83K | -1.71M | -1.46M | -972.12K | -1.42M | -1.72M | -881.8K | -2.44M | -3.88M | -5.34M | -6.37M | -14.41M | -4.72M | -6.11M | -4.1M | -3.74M | -3.07M | -1.85M |
Net Income | -957.83K | -1.71M | -1.46M | -972.12K | -1.42M | -1.72M | -881.8K | -2.44M | -3.88M | -5.34M | -6.37M | -14.41M | -4.72M | -6.11M | -4.1M | -3.74M | -3.07M | -1.85M |
Selling & General & Admin | 849.18K | 1.64M | 1.31M | 869.24K | 1.25M | 1.53M | 910.75K | 1.5M | 1.62M | 1.7M | 1.79M | 1.83M | 1.84M | 1.68M | 1.45M | 1.73M | 1.59M | 1.33M |
Research & Development | 116.38K | 75.53K | 175.34K | 137.23K | 214.45K | 243K | 59.95K | 1.04M | 2.35M | 3.73M | 4.69M | 3.79M | 2.92M | 4.44M | 2.7M | 2.02M | 2.1M | 1.74M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 965.57K | 1.72M | 1.49M | 1.01M | 1.47M | 1.77M | 970.7K | 2.53M | 3.97M | 5.42M | 6.48M | 5.62M | 4.76M | 6.12M | 4.14M | 3.75M | 3.69M | 3.07M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.25K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 965.57K | 1.72M | 1.49M | 1.01M | 1.47M | 1.77M | 970.7K | 2.53M | 3.97M | 5.42M | 6.48M | 5.62M | 4.76M | 6.12M | 4.14M | 3.75M | 3.69M | 3.07M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 142.23K | 111.48K | 64.47K | 85.89K | 40.23K | 35.13K | 32.98K | 31.42K | 22.69K | 20.03K | 18.83K | 18.82K | 17.89K | 15.5K | 15.15K | 15.01K | 14.94K | 10.23K |
Shares Outstanding (Diluted) | 142.23K | 111.48K | 64.47K | 85.89K | 40.23K | 35.13K | 32.98K | 31.44K | 22.69K | 20.03K | 18.87K | 18.82K | 17.93K | 15.5K | 15.15K | 15.01K | 14.99K | 10.23K |
EPS (Basic) | -6.75 | -15.45 | -22.8 | -11.4 | -35.55 | -49.05 | -26.85 | -78.15 | -171.75 | -267.6 | -43.2 | -769.2 | -270 | -396 | -270 | -250.8 | -210 | -180 |
EPS (Diluted) | -6.75 | -15.45 | -22.8 | -11.4 | -35.55 | -49.05 | -26.85 | -78.15 | -171.75 | -267.6 | -43.2 | -769.2 | -270 | -396 | -270 | -250.8 | -210 | -180 |
EBITDA | -957.83K | -1.71M | -1.49M | -1.01M | -1.47M | -1.77M | -969.6K | -2.53M | -3.97M | -5.42M | -6.48M | -5.62M | -4.76M | -6.11M | -4.14M | -3.74M | -3.11M | -1.8M |
EBIT | -957.83K | -1.71M | -1.49M | -1.01M | -1.47M | -1.77M | -970.7K | -2.53M | -3.97M | -5.42M | -6.48M | -5.62M | -4.76M | -6.12M | -4.14M | -3.75M | -3.12M | -1.8M |
Depreciation & Amortization | n/a | 1.11K | 1.11K | 1.1K | 1.11K | 1.11K | 1.1K | 5.61K | 1.67K | 1.67K | 1.67K | 1.67K | 1.67K | 4.8K | 4.8K | 4.8K | 4.8K | 4.79K |